Under the current circumstances, if pharmaceutical companies are to maintain existing trials – or satisfactorily recruit for new trials – they must consider adopting decentralized models, delivering treatment Direct-to-Patient (DtP), gathering data from participants’ homes. 

Discover how adaptive design can support the success of complex clinical trials in this white paper, put together with our partners at Xcenda, where we assess the benefits and risks associated with adaptive design and look at the learnings we can take from this approach. 

Learn why the biopharmaceutical industry is undergoing a shift to a more patient-centric approach.

In this infographic, we demonstrate the 12 steps for international air shipments, identify potential risks in the supply chain and illustrate how World Courier works to avoid them.

With global disruptions and requirement for continuity of supply, ensuring confidence in your supply chain has never been more critical. 

To help our customers work in the changing landscape of COVID-19, we’ve been researching how organizations have adapted their approach and how they believe practices will change moving forwards. During this webinar, we present the results.

In response to the impact of COVID-19, organizations across all industries are re-thinking processes and establishing creative solutions. A core focus is on maintaining continuity of medical supply.

In light of the rapid evolution of the situation in Europe and globally, due to the dynamic nature of the Covid-19 outbreak, the enablement of at home clinical trials and specialty delivery programs is now critical.